Sign In
Buy CLDX
$33.41
+0.98 (+3.02%)
At Close: Jun 22, 2026
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Celldex Therapeutics, Inc. (CLDX) announced today that the Company will receive a $1.7 million payment related to an existing 2013 agreement with Rockefeller University under which Celldex performed m
The "Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.
The "Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.
Global Cancer Immunotherapy Market Opportunity, Dosage, Price and Clinical Trials Insight 2020-2026
02:58pm, Wednesday, 26'th Feb 2020
Dublin, Feb. 26, 2020 -- The "Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" report has been added to.
94 Biggest Movers From Friday
09:53am, Monday, 24'th Feb 2020
Gainers
Trans World Entertainment Corporation (NASDAQ: TWMC) shares jumped 50.9% to close at $5.28 on Friday after the company disclosed that its subsidiary etailz entered into a...
Mid-Day Market Update: Dropbox Jumps On Upbeat Q4 Results; Lianluo Smart Shares Plummet
05:09pm, Friday, 21'st Feb 2020
Midway through trading Friday, the Dow traded down 0.82% to 28979.46 while the NASDAQ fell 1.26% to 9,628.04. The S&P also fell, dropping 0.93% to 3,342.02.
Leading and...
Mid-Morning Market Update: Markets Open Lower; Deere Beats Q4 Expectations
03:19pm, Friday, 21'st Feb 2020
Following the market opening Friday, the Dow traded down 0.92% to 28951.46 while the NASDAQ fell 1.42% to 9,612.15. The S&P also fell, dropping 0.97% to 3,340.60.
Leading and...
S, DE among premarket gainers
02:24pm, Friday, 21'st Feb 2020
DPW Holdings (NYSEMKT:DPW) +38% after defense unit gets $1.4M follow-on order.California Resources (NYSE:CRC) +26% on exchange offers and subscriptions.Baudax Bio (NASDAQ:BXRX) +23% on FDA nod
Is Celldex Therapeutics, Inc. (CLDX) A Good Stock To Buy?
03:26pm, Monday, 23'rd Dec 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks a
Celldex (CLDX) Down 3.9% Since Last Earnings Report: Can It Rebound?
04:30pm, Thursday, 12'th Dec 2019
Celldex (CLDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celldex Initiates Phase 1 Study of KIT Inhibitor CDX-0159
01:01pm, Monday, 18'th Nov 2019
Celldex Therapeutics, Inc. (CLDX) announced today that a Phase 1a study of CDX-0159 has initiated in healthy volunteers. CDX-0159 is a humanized monoclonal antibody that specifically binds the KIT re
Celldex (CLDX) Q3 Loss Narrower Than Expected, Revenues Miss
02:44pm, Thursday, 14'th Nov 2019
Celldex (CLDX) reports mixed third-quarter results. Its revenues fall on reduced collaboration and contract revenues.
Celldex Therapeutics (CLDX) Reports Q3 Loss, Lags Revenue Estimates
02:25pm, Tuesday, 12'th Nov 2019
Celldex (CLDX) delivered earnings and revenue surprises of 10.71% and -56.67%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
